390 related articles for article (PubMed ID: 18663533)
21. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
22. Cytometric profiling of CD133+ cells in human colon
carcinoma cell lines identifies a common core phenotype
and cell type-specific mosaics.
Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
[TBL] [Abstract][Full Text] [Related]
23. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.
He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y
J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420
[TBL] [Abstract][Full Text] [Related]
24. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
[TBL] [Abstract][Full Text] [Related]
25. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
[TBL] [Abstract][Full Text] [Related]
26. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
[TBL] [Abstract][Full Text] [Related]
27. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
[TBL] [Abstract][Full Text] [Related]
28. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
[TBL] [Abstract][Full Text] [Related]
29. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
Huang X; Sheng Y; Guan M
Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
[TBL] [Abstract][Full Text] [Related]
30. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.
Fang Y; Xiang J; Chen Z; Gu X; Li Z; Tang F; Zhou Z
Oncol Rep; 2012 Dec; 28(6):2115-24. PubMed ID: 23007737
[TBL] [Abstract][Full Text] [Related]
31. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
O'Brien CA; Pollett A; Gallinger S; Dick JE
Nature; 2007 Jan; 445(7123):106-10. PubMed ID: 17122772
[TBL] [Abstract][Full Text] [Related]
32. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.
Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F
Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178
[TBL] [Abstract][Full Text] [Related]
33. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
[TBL] [Abstract][Full Text] [Related]
34. Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.
Fedr R; Pernicová Z; Slabáková E; Straková N; Bouchal J; Grepl M; Kozubík A; Souček K
Cytometry A; 2013 May; 83(5):472-82. PubMed ID: 23450810
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
36. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
[TBL] [Abstract][Full Text] [Related]
37. Identification and expansion of human colon-cancer-initiating cells.
Ricci-Vitiani L; Lombardi DG; Pilozzi E; Biffoni M; Todaro M; Peschle C; De Maria R
Nature; 2007 Jan; 445(7123):111-5. PubMed ID: 17122771
[TBL] [Abstract][Full Text] [Related]
38. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
39. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
[TBL] [Abstract][Full Text] [Related]
40. [Role of CD44(+)/ESA(+) in sorting colonic cancer stem cells].
Xue FQ; Yang GH; Huang RL
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):896-8. PubMed ID: 22116729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
